(Q28260348)

https://api.crossref.org/works/10.1038/SJ.ONC.1210879

Involvement of human polynucleotide kinase in double-strand break repair by non-homologous end joining

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210879

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210879

Checkpoints: controls that ensure the order of cell cycle events

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210879

Genome maintenance mechanisms for preventing cancer

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210879

The concept of synthetic lethality in the context of anticancer therapy

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210879

Human polynucleotide kinase participates in repair of DNA double-strand breaks by nonhomologous end joining but not homologous recombination

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210879

Instability and decay of the primary structure of DNA

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210879

Isolation of a small molecule inhibitor of DNA base excision repair.

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210879

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210879

A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci.

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210879

Enhanced expression of poly(ADP-ribose) synthetase gene in malignant lymphoma

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210879

RETRACTED: Small molecule-based reversible reprogramming of cellular lifespan

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210879

Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes

20 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210879

Cell cycle checkpoint signaling through the ATM and ATR kinases

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

20 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

A role for polymerase eta in the cellular tolerance to cisplatin-induced damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

The overexpression of specialized DNA polymerases in cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Chk1 and Chk2 kinases in checkpoint control and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

ATM activation in normal human tissues and testicular cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Regulation of poly(ADP-ribose) metabolism by poly(ADP-ribose) glycohydrolase: where and when?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Biochemical and cellular characterization of VRX0466617, a novel and selective inhibitor for the checkpoint kinase Chk2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

PARP-1, PARP-2, and the cellular response to low doses of ionizing radiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

PARP inhibitors for cancer therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

The inhibition and treatment of breast cancer with poly (ADP-ribose) polymerase (PARP-1) inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

(ADP-ribose)n participates in DNA excision repair

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Going APE over ref-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Principles for the buffering of genetic variation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Efficient Deletion of NormalBrca2-Deficient Intestinal Epithelium by Poly(ADP-Ribose) Polymerase Inhibition Models Potential Prophylactic Therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of [...]

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Identification of small molecule synthetic inhibitors of DNA polymerase beta by NMR chemical shift mapping.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

SU11752 inhibits the DNA-dependent protein kinase and DNA double-strand break repair resulting in ionizing radiation sensitization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

1 reference

7 January 2021

DNA damage-induced activation of ATM and ATM-dependent signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

ATM activation and DNA damage response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

The response of Parp knockout mice against DNA damaging agents.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of Poly (ADP-Ribose) polymerase: an issue of potency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

ATR inhibition selectively sensitizes G1 checkpoint-deficient cells to lethal premature chromatin condensation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

High-performance affinity beads for identifying drug receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Enhanced polyadenosine diphosphate-ribosylation in cirrhotic liver and carcinoma tissues in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

The DNA-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Poly(ADP-ribose) polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

The therapeutic potential of poly(ADP-ribose) polymerase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210879

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210879

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

3481533

1008594663

0 references

3481533

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference